Posts Tagged ‘Neuronostics’
Neuronostics forms strategic partnership to deliver integrated EEG solutions for clinical trials
Neuroelectrics, a pioneer in high-definition brain stimulation and EEG technology, has partnered with Neuronostics, an innovator in advanced digital biomarkers and EEG analysis, to deliver an integrated EEG solution tailored for the pharmaceutical, contract research organizations (CROs) and academic partners. This collaboration combines Neuroelectrics’ cutting-edge EEG hardware with Neuronostics’ proprietary analytics to streamline clinical trials…
Read MoreNeuronostics reach final of global competition
Neuronostics, a SETsquared Bristol member, is one of four finalists for the Nature Spinoff Prize 2021. The finalists were chosen for their potential to translate world-leading scientific research into products and services that would have lasting impact on society. Neuronostics was co-founded by Professor John Terry and Dr Wessel Woldman in 2018. Since that time,…
Read MoreNeuronostics close oversubscribed seed funding round
SETsquared Bristol member, Neuronostics, an award-winning SME, has successfully secured £300K for the ongoing development of its revolutionary clinical decision support systems. The funds being received from a group of private investors who are establishing a new venture capital fund QantX Ventures. Neuronostics has developed patented technology that enables faster and more accurate diagnosis of…
Read More